These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 32280711

  • 1. N1-Methylnicotinamide Improves Hepatic Insulin Sensitivity via Activation of SIRT1 and Inhibition of FOXO1 Acetylation.
    Zhang J, Chen Y, Liu C, Li L, Li P.
    J Diabetes Res; 2020; 2020():1080152. PubMed ID: 32280711
    [Abstract] [Full Text] [Related]

  • 2. N1‑methylnicotinamide ameliorates insulin resistance in skeletal muscle of type 2 diabetic mice by activating the SIRT1/PGC‑1α signaling pathway.
    Chen Y, Zhang J, Li P, Liu C, Li L.
    Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33576435
    [Abstract] [Full Text] [Related]

  • 3. Gegen Qinlian Decoction Ameliorates Hepatic Insulin Resistance by Silent Information Regulator1 (SIRT1)-Dependent Deacetylation of Forkhead Box O1 (FOXO1).
    Sui M, Chen G, Mao X, Wei X, Chen Y, Liu C, Fan Y.
    Med Sci Monit; 2019 Nov 13; 25():8544-8553. PubMed ID: 31719515
    [Abstract] [Full Text] [Related]

  • 4. Sodium meta-arsenite ameliorates hyperglycemia in obese diabetic db/db mice by inhibition of hepatic gluconeogenesis.
    Lee YS, Lee EK, Oh HH, Choi CS, Kim S, Jun HS.
    J Diabetes Res; 2014 Nov 13; 2014():961732. PubMed ID: 25610880
    [Abstract] [Full Text] [Related]

  • 5. Yunpi Heluo decoction attenuates insulin resistance by regulating SIRT1-FoxO1 autophagy pathway in skeletal muscle of Zucker diabetic fatty rats.
    Mao ZJ, Xia WS, Chai F.
    J Ethnopharmacol; 2021 Apr 24; 270():113828. PubMed ID: 33476712
    [Abstract] [Full Text] [Related]

  • 6. Leucine supplementation increases SIRT1 expression and prevents mitochondrial dysfunction and metabolic disorders in high-fat diet-induced obese mice.
    Li H, Xu M, Lee J, He C, Xie Z.
    Am J Physiol Endocrinol Metab; 2012 Nov 15; 303(10):E1234-44. PubMed ID: 22967499
    [Abstract] [Full Text] [Related]

  • 7. Acute exercise reduces hepatic glucose production through inhibition of the Foxo1/HNF-4alpha pathway in insulin resistant mice.
    De Souza CT, Frederico MJ, da Luz G, Cintra DE, Ropelle ER, Pauli JR, Velloso LA.
    J Physiol; 2010 Jun 15; 588(Pt 12):2239-53. PubMed ID: 20421289
    [Abstract] [Full Text] [Related]

  • 8. SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats.
    Erion DM, Yonemitsu S, Nie Y, Nagai Y, Gillum MP, Hsiao JJ, Iwasaki T, Stark R, Weismann D, Yu XX, Murray SF, Bhanot S, Monia BP, Horvath TL, Gao Q, Samuel VT, Shulman GI.
    Proc Natl Acad Sci U S A; 2009 Jul 07; 106(27):11288-93. PubMed ID: 19549853
    [Abstract] [Full Text] [Related]

  • 9. MiR-542-5p Inhibits Hyperglycemia and Hyperlipoidemia by Targeting FOXO1 in the Liver.
    Tian F, Ying HM, Wang YY, Cheng BN, Chen J.
    Yonsei Med J; 2020 Sep 07; 61(9):780-788. PubMed ID: 32882762
    [Abstract] [Full Text] [Related]

  • 10. A bioinformatics and transcriptomics based investigation reveals an inhibitory role of Huanglian-Renshen-Decoction on hepatic glucose production of T2DM mice via PI3K/Akt/FoxO1 signaling pathway.
    Wu F, Shao Q, Xia Q, Hu M, Zhao Y, Wang D, Fang K, Xu L, Zou X, Chen Z, Chen G, Lu F.
    Phytomedicine; 2021 Mar 07; 83():153487. PubMed ID: 33636476
    [Abstract] [Full Text] [Related]

  • 11. SIRT1 mediates the role of RNA-binding protein QKI 5 in the synthesis of triglycerides in non-alcoholic fatty liver disease mice via the PPARα/FoxO1 signaling pathway.
    Zhang W, Sun Y, Liu W, Dong J, Chen J.
    Int J Mol Med; 2019 Mar 07; 43(3):1271-1280. PubMed ID: 30664220
    [Abstract] [Full Text] [Related]

  • 12. Hepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance.
    Wang RH, Kim HS, Xiao C, Xu X, Gavrilova O, Deng CX.
    J Clin Invest; 2011 Nov 07; 121(11):4477-90. PubMed ID: 21965330
    [Abstract] [Full Text] [Related]

  • 13. Mibefradil reduces hepatic glucose output in HepG2 cells via Ca2+/calmodulin-dependent protein kinase II-dependent Akt/forkhead box O1signaling.
    Ying D, Mengya S, Peilin L, Lingong Z, Huan M, Jing X, Le Z, Kebin Z, Bin C, Jun Y, Shaodong G, Zihui X.
    Eur J Pharmacol; 2021 Sep 15; 907():174296. PubMed ID: 34224697
    [Abstract] [Full Text] [Related]

  • 14. Prostaglandin F2α Facilitates Hepatic Glucose Production Through CaMKIIγ/p38/FOXO1 Signaling Pathway in Fasting and Obesity.
    Wang Y, Yan S, Xiao B, Zuo S, Zhang Q, Chen G, Yu Y, Chen D, Liu Q, Liu Y, Shen Y, Yu Y.
    Diabetes; 2018 Sep 15; 67(9):1748-1760. PubMed ID: 29773555
    [Abstract] [Full Text] [Related]

  • 15. Spexin alleviates insulin resistance and inhibits hepatic gluconeogenesis via the FoxO1/PGC-1α pathway in high-fat-diet-induced rats and insulin resistant cells.
    Gu L, Ding X, Wang Y, Gu M, Zhang J, Yan S, Li N, Song Z, Yin J, Lu L, Peng Y.
    Int J Biol Sci; 2019 Sep 15; 15(13):2815-2829. PubMed ID: 31853220
    [Abstract] [Full Text] [Related]

  • 16. Estrogen Improves Insulin Sensitivity and Suppresses Gluconeogenesis via the Transcription Factor Foxo1.
    Yan H, Yang W, Zhou F, Li X, Pan Q, Shen Z, Han G, Newell-Fugate A, Tian Y, Majeti R, Liu W, Xu Y, Wu C, Allred K, Allred C, Sun Y, Guo S.
    Diabetes; 2019 Feb 15; 68(2):291-304. PubMed ID: 30487265
    [Abstract] [Full Text] [Related]

  • 17. Reciprocal Regulation of Hepatic TGF-β1 and Foxo1 Controls Gluconeogenesis and Energy Expenditure.
    Pan Q, Ai W, Chen Y, Kim DM, Shen Z, Yang W, Jiang W, Sun Y, Safe S, Guo S.
    Diabetes; 2023 Sep 01; 72(9):1193-1206. PubMed ID: 37343276
    [Abstract] [Full Text] [Related]

  • 18. Feedback regulation of hepatic gluconeogenesis through modulation of SHP/Nr0b2 gene expression by Sirt1 and FoxO1.
    Wei D, Tao R, Zhang Y, White MF, Dong XC.
    Am J Physiol Endocrinol Metab; 2011 Feb 01; 300(2):E312-20. PubMed ID: 21081708
    [Abstract] [Full Text] [Related]

  • 19. Elucidation of the anti-β-cell dedifferentiation mechanism of a modified Da Chaihu Decoction by an integrative approach of network pharmacology and experimental verification.
    Chen H, Guo J, Cai Y, Zhang C, Wei F, Sun H, Cheng C, Liu W, He Z.
    J Ethnopharmacol; 2024 Mar 01; 321():117481. PubMed ID: 38007164
    [Abstract] [Full Text] [Related]

  • 20. Silymarin ameliorates the disordered glucose metabolism of mice with diet-induced obesity by activating the hepatic SIRT1 pathway.
    Feng B, Huang B, Jing Y, Shen S, Feng W, Wang W, Meng R, Zhu D.
    Cell Signal; 2021 Aug 01; 84():110023. PubMed ID: 33901577
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.